Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study. [electronic resource]
Producer: 20030709Description: 379-83 p. digitalISSN:- 0902-4441
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- B-Lymphocytes -- drug effects
- Clone Cells -- drug effects
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Feasibility Studies
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Neoplastic Cells, Circulating -- drug effects
- Remission Induction
- Vidarabine -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.